HK1220495A1 - 從材料和組合物中檢測和富集病原體的方法 - Google Patents

從材料和組合物中檢測和富集病原體的方法

Info

Publication number
HK1220495A1
HK1220495A1 HK16108498.2A HK16108498A HK1220495A1 HK 1220495 A1 HK1220495 A1 HK 1220495A1 HK 16108498 A HK16108498 A HK 16108498A HK 1220495 A1 HK1220495 A1 HK 1220495A1
Authority
HK
Hong Kong
Prior art keywords
enrichment
compositions
materials
methods
pathogen detection
Prior art date
Application number
HK16108498.2A
Other languages
English (en)
Inventor
R HENN Matthew
G Aunins John
Berry David
N Cook David
Original Assignee
Seres Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Seres Therapeutics Inc filed Critical Seres Therapeutics Inc
Publication of HK1220495A1 publication Critical patent/HK1220495A1/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
HK16108498.2A 2013-03-14 2016-07-18 從材料和組合物中檢測和富集病原體的方法 HK1220495A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361781854P 2013-03-14 2013-03-14
PCT/US2014/029539 WO2014153194A2 (en) 2013-03-14 2014-03-14 Methods for pathogen detection and enrichment from materials and compositions

Publications (1)

Publication Number Publication Date
HK1220495A1 true HK1220495A1 (zh) 2017-05-05

Family

ID=51581772

Family Applications (1)

Application Number Title Priority Date Filing Date
HK16108498.2A HK1220495A1 (zh) 2013-03-14 2016-07-18 從材料和組合物中檢測和富集病原體的方法

Country Status (4)

Country Link
US (1) US20160040215A1 (zh)
EP (1) EP2971148A4 (zh)
HK (1) HK1220495A1 (zh)
WO (1) WO2014153194A2 (zh)

Families Citing this family (96)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120077206A1 (en) 2003-07-12 2012-03-29 Accelr8 Technology Corporation Rapid Microbial Detection and Antimicrobial Susceptibility Testing
EP1648286B1 (en) 2003-07-12 2017-12-20 Accelerate Diagnostics, Inc. Sensitive and rapid biodetection
WO2011094027A1 (en) 2010-02-01 2011-08-04 Hlavka Edwin J Bacteriotherapy for clostridium difficile colitis
WO2011151941A1 (ja) 2010-06-04 2011-12-08 国立大学法人東京大学 制御性ｔ細胞の増殖または集積を誘導する作用を有する組成物
ES2551922T3 (es) 2011-03-07 2015-11-24 Accelerate Diagnostics, Inc. Sistemas rápidos de purificación celular
US10254204B2 (en) 2011-03-07 2019-04-09 Accelerate Diagnostics, Inc. Membrane-assisted purification
GB201112091D0 (en) 2011-07-14 2011-08-31 Gt Biolog Ltd Bacterial strains isolated from pigs
GB201117313D0 (en) 2011-10-07 2011-11-16 Gt Biolog Ltd Bacterium for use in medicine
US10238694B2 (en) 2011-12-01 2019-03-26 The University Of Tokyo Human-derived bacteria that induce proliferation or accumulation of regulatory T cells
US9650628B2 (en) 2012-01-26 2017-05-16 Nugen Technologies, Inc. Compositions and methods for targeted nucleic acid sequence enrichment and high efficiency library regeneration
BR112014021388A2 (pt) 2012-02-29 2017-07-18 Ethicon Endo Surgery Inc composições de microbiota e métodos rela-cionados às mesmas
WO2013139861A1 (en) 2012-03-20 2013-09-26 Luc Montagnier Methods and pharmaceutical compositions of the treatment of autistic syndrome disorders
CA3107450A1 (en) 2012-03-29 2013-10-03 Therabiome, Llc Gastrointestinal site-specific oral vaccination formulations active on the ileum and appendix
GB2518078B (en) 2012-06-18 2015-04-29 Nugen Technologies Inc Compositions and methods for negative selection of non-desired nucleic acid sequences
US20150011396A1 (en) 2012-07-09 2015-01-08 Benjamin G. Schroeder Methods for creating directional bisulfite-converted nucleic acid libraries for next generation sequencing
US8906668B2 (en) 2012-11-23 2014-12-09 Seres Health, Inc. Synergistic bacterial compositions and methods of production and use thereof
EP3584308A3 (en) 2013-02-04 2020-03-04 Seres Therapeutics, Inc. Compositions and methods
US10973861B2 (en) 2013-02-04 2021-04-13 Seres Therapeutics, Inc. Compositions and methods
NZ711298A (en) 2013-03-14 2021-07-30 Therabiome Llc Targeted gastrointestinal tract delivery of probiotic organisms and/or therapeutic agents
JP2016519664A (ja) 2013-03-15 2016-07-07 セレス セラピューティクス インコーポレイテッド ネットワークを基にした微生物組成物及び方法
US9677109B2 (en) 2013-03-15 2017-06-13 Accelerate Diagnostics, Inc. Rapid determination of microbial growth and antimicrobial susceptibility
US9340817B2 (en) 2013-03-27 2016-05-17 Sample6 Technologies, Inc. Methods of making recombinant phage, compositions and articles of manufacture of same for bacterial detection
GB201306536D0 (en) 2013-04-10 2013-05-22 Gt Biolog Ltd Polypeptide and immune modulation
US10383901B2 (en) 2013-06-05 2019-08-20 Rebiotix, Inc. Microbiota restoration therapy (MRT), compositions and methods of manufacture
US9694039B2 (en) 2013-06-05 2017-07-04 Rebiotix, Inc. Microbiota restoration therapy (MRT), compositions and methods of manufacture
US9782445B2 (en) 2013-06-05 2017-10-10 Rebiotix, Inc. Microbiota restoration therapy (MRT), compositions and methods of manufacture
WO2014205221A2 (en) * 2013-06-19 2014-12-24 Sample6 Technologies, Inc. Phage-based bacterial detection assay
JP6637885B2 (ja) 2013-07-21 2020-01-29 ペンデュラム セラピューティクス， インコーポレイテッド マイクロバイオームの特性解明、モニタリング、および処置のための方法およびシステム
MX367109B (es) 2013-11-25 2019-08-05 Seres Therapeutics Inc Composiciones bacterianas sinergicas y sus metodos de produccion y usos.
EP3082431A4 (en) 2013-12-16 2017-11-15 Seres Therapeutics, Inc. Bacterial compositions and methods of use thereof for treatment of immune system disorders
CN108064132A (zh) 2014-10-31 2018-05-22 霍勒拜欧姆公司 与病症的微生物治疗和诊断有关的方法和组合物
JP6777643B2 (ja) * 2014-11-25 2020-10-28 メモリアル スローン ケタリング キャンサー センター 腸内微生物叢及びｇｖｈｄ
MA41020A (fr) 2014-11-25 2017-10-03 Evelo Biosciences Inc Compositions probiotiques et prébiotiques, et leurs procédés d'utilisation pour la modulation du microbiome
ES2658310T3 (es) 2014-12-23 2018-03-09 4D Pharma Research Limited Una cepa de bacteroides thetaiotaomicron y su uso en la reducción de la inflamación
SI3193901T1 (en) 2014-12-23 2018-06-29 4D Pharma Research Limited Pirin polypeptide and immune modulation
GB201505364D0 (en) * 2015-03-27 2015-05-13 Genetic Analysis As Method for determining gastrointestinal tract dysbiosis
EP3278115A2 (en) 2015-03-30 2018-02-07 Accelerate Diagnostics, Inc. Instrument and system for rapid microorganism identification and antimicrobial agent susceptibility testing
US10253355B2 (en) 2015-03-30 2019-04-09 Accelerate Diagnostics, Inc. Instrument and system for rapid microorganism identification and antimicrobial agent susceptibility testing
CA2985848A1 (en) * 2015-04-23 2016-10-27 Bd Kiestra B.V. An automated method for evaluating microbial growth using colony contrast
KR20230174291A (ko) 2015-05-06 2023-12-27 스니프르 테크놀로지스 리미티드 미생물 개체군 변경 및 미생물군 변형
US20160362680A1 (en) * 2015-05-15 2016-12-15 Nugen Technologies, Inc. Compositions and methods for negative selection of non-desired nucleic acid sequences
US10799539B2 (en) 2015-06-09 2020-10-13 Rebiotix, Inc. Microbiota restoration therapy (MRT) compositions and methods of manufacture
US10905726B2 (en) 2015-06-09 2021-02-02 Rebiotix, Inc. Microbiota restoration therapy (MRT) compositions and methods of manufacture
KR102066242B1 (ko) 2015-06-09 2020-01-14 리바이오틱스, 인코퍼레이티드 미생물상 복원 치료(mrt) 조성물 및 제조 방법
US10828340B2 (en) 2015-06-09 2020-11-10 Rebiotix, Inc. Microbiota restoration therapy (MRT) compositions and methods of manufacture
MD3307288T2 (ro) 2015-06-15 2019-12-31 4D Pharma Res Ltd Compoziții care conțin tulpini bacteriene
MA41060B1 (fr) 2015-06-15 2019-11-29 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
HUE045754T2 (hu) 2015-06-15 2020-01-28 4D Pharma Res Ltd Blautia stercosis és wexlerae gyulladásos és autoimmun betegségek kezelésében történõ alkalmazásra
EP3650033B1 (en) 2015-06-15 2022-02-16 4D Pharma Research Limited Compositions comprising bacterial strains
MA41010B1 (fr) 2015-06-15 2020-01-31 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
EP4242328A3 (en) * 2015-09-04 2024-02-21 Memorial Sloan-Kettering Cancer Center Methods for detecting risk of cancer relapse using eubacterium limosum
KR20180093903A (ko) * 2015-11-03 2018-08-22 더 브리검 앤드 우먼즈 하스피털, 인크. 음식 알레르기의 치료 및/또는 예방을 위한 치료용 미생물총
TWI797067B (zh) 2015-11-20 2023-04-01 英商4D製藥研究有限公司 包含細菌菌株之組合物
GB201520497D0 (en) 2015-11-20 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
GB201520631D0 (en) 2015-11-23 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
GB201520638D0 (en) 2015-11-23 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
WO2017100420A1 (en) * 2015-12-08 2017-06-15 Mayo Foundation For Medical Education And Research Biomarkers for predicting clostridium difficile infection treatment outcome
WO2017132319A2 (en) * 2016-01-27 2017-08-03 Regents Of The University Of Minnesota Methods of attaching probes to microorganisms and methods of use thereof
EP3413902A4 (en) * 2016-02-11 2019-11-13 Nubyiota LLC SYSTEMS AND METHOD FOR CHARACTERIZING COMPOSITIONS WITH BACTERIAL POPULATIONS FROM FECALIA
CN114712405A (zh) 2016-03-04 2022-07-08 4D制药有限公司 包含细菌菌株的组合物
GB201612191D0 (en) 2016-07-13 2016-08-24 4D Pharma Plc Compositions comprising bacterial strains
US10894990B2 (en) 2016-05-17 2021-01-19 Shoreline Biome, Llc High throughput method for identification and sequencing of unknown microbial and eukaryotic genomes from complex mixtures
US11707493B2 (en) 2016-05-23 2023-07-25 California Institute Of Technology Regulate gut microbiota to treat neurodegenerative disorders
GB201609811D0 (en) 2016-06-05 2016-07-20 Snipr Technologies Ltd Methods, cells, systems, arrays, RNA and kits
US9999641B2 (en) 2016-06-14 2018-06-19 Vedanta Biosciences, Inc. Treatment of clostridium difficile infection
TW201821093A (zh) 2016-07-13 2018-06-16 英商４Ｄ製藥有限公司 包含細菌菌株之組合物
GB201621123D0 (en) 2016-12-12 2017-01-25 4D Pharma Plc Compositions comprising bacterial strains
US20200011873A1 (en) * 2017-03-17 2020-01-09 Second Genome, Inc. Leveraging sequence-based fecal microbial community survey data to identify a composite biomarker for colorectal cancer
CA3097521C (en) 2017-05-15 2023-10-17 Axial Biotherapeutics, Inc. Inhibitors of microbially induced amyloid
WO2018213262A1 (en) 2017-05-19 2018-11-22 Memorial Sloan-Kettering Cancer Center Methods and compositions for reducing listeria monocytogenes infection or colonization
WO2018215758A1 (en) 2017-05-22 2018-11-29 4D Pharma Research Limited Compositions comprising bacterial strains
EP3630942B1 (en) 2017-05-24 2022-11-30 4D Pharma Research Limited Compositions comprising bacterial strain
CA3066561C (en) 2017-06-14 2022-07-19 4D Pharma Research Limited Compositions comprising a bacterial strain of the genus megasphera and uses thereof
PT3638271T (pt) 2017-06-14 2021-01-05 4D Pharma Res Ltd Composições contendo estirpes bacterianas
CN107164438B (zh) * 2017-07-13 2021-03-23 陕西科技大学 一种提高短短芽孢杆菌细菌素生产水平的发酵方法
US20210317508A1 (en) * 2017-08-01 2021-10-14 Axial Therapeutics, Inc. Methods and apparatus for determining risk of autism spectrum disorder
WO2019036510A1 (en) 2017-08-14 2019-02-21 Seres Therapeutics, Inc. COMPOSITIONS AND METHODS FOR TREATING CHOLESTATIC DISEASE
CA3073838A1 (en) 2017-08-30 2019-03-07 Pendulum Therapeutics, Inc. Methods and compositions for treatment of microbiome-associated disorders
CN111432826A (zh) * 2017-10-30 2020-07-17 赛里斯治疗公司 用于治疗抗生素耐药性的组合物和方法
CN111615562A (zh) * 2017-11-16 2020-09-01 美国分子实验室公司 检测抗生素耐受性幽门螺旋杆菌的方法
CN111902213B (zh) * 2018-01-29 2022-12-06 简·探针公司 分析系统和方法
US10760075B2 (en) 2018-04-30 2020-09-01 Snipr Biome Aps Treating and preventing microbial infections
AU2019351019A1 (en) 2018-09-27 2021-04-22 Research Development Foundation Methods and probiotic compositions for the treatment of bone disorders
CN111019873B (zh) * 2018-10-09 2022-08-19 安徽吐露港生物科技有限公司 在食气梭菌基因组上快速整合大片段dna的方法
WO2020135689A1 (en) * 2018-12-27 2020-07-02 The Chinese University Of Hong Kong Therapeutic and prophylactic use of microorganisms
MX2021014328A (es) * 2019-05-23 2022-03-17 American Molecular Laboratories Inc Métodos para detección de secuencias de adn raras en muestras fecales.
CN110699468B (zh) * 2019-10-29 2023-05-02 圣湘生物科技股份有限公司 检测人肠道细菌的组合物、试剂盒及方法
WO2021091806A1 (en) * 2019-11-08 2021-05-14 Virginia Commonwealth University Changing gut microbiota to reduce alcohol craving
CN113122646A (zh) * 2020-01-15 2021-07-16 中国科学院昆明动物研究所 炎性肠病特异性肠道微生物检测靶标及其应用
TW202203950A (zh) * 2020-03-30 2022-02-01 香港商香港微生物菌群創新中心有限公司 微生物在調節體重和膽固醇水準中的用途
WO2022108982A1 (en) * 2020-11-17 2022-05-27 Yale University Targeting host-bacteria interactions for the treatment of microbiota-mediated diseases
WO2022112526A1 (en) 2020-11-26 2022-06-02 4D Pharma Leon, S.L.U. Process
CN113493847B (zh) * 2021-06-24 2022-04-19 北京工业大学 基于PMA高通量测序和PICRUSt的抗生素抗性基因及潜在宿主细菌的鉴定方法
FR3125124A1 (fr) * 2021-07-07 2023-01-13 Commissariat A L'energie Atomique Et Aux Energies Alternatives Procédé d'analyse d'un échantillon pour y détecter la présence d'une forme active d'une espèce biologique
WO2023177875A1 (en) * 2022-03-17 2023-09-21 Evelo Biosciences, Inc. Methods and compositions for anaerobic contaminant testing
JP7279983B1 (ja) 2022-09-21 2023-05-23 学校法人近畿大学 腸内細菌培養組培地、及び腸内細菌培養方法。

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPO430496A0 (en) * 1996-12-19 1997-01-23 Arnott's Biscuits Limited Prebiotics and probiotics
US20050048515A1 (en) * 2003-08-29 2005-03-03 Garner Bryan E. Methods for detecting and quantifying specific probiotic microorganisms in animal feed
PL1812585T3 (pl) * 2004-11-01 2015-03-31 Erber Ag Bakteriofagi jako czynniki selekcyjne
GB0916335D0 (en) * 2009-09-17 2009-10-28 Martin W J Medicaments

Also Published As

Publication number Publication date
EP2971148A4 (en) 2016-08-17
WO2014153194A2 (en) 2014-09-25
US20160040215A1 (en) 2016-02-11
WO2014153194A3 (en) 2014-12-11
WO2014153194A4 (en) 2015-01-15
EP2971148A2 (en) 2016-01-20

Similar Documents

Publication Publication Date Title
HK1220495A1 (zh) 從材料和組合物中檢測和富集病原體的方法
IL274464B1 (en) Preparations and methods for the detection of rare sequence variants
IL273205A (en) Preparations and methods
IL272171B (en) The compositions for the analysis of the interaction between RNA and chromatin, and their uses
HK1218837A1 (zh) 組合物和方法
HK1218560A1 (zh) 組成與方法
EP3013957A4 (en) COMPOSITIONS AND METHODS FOR SAMPLE PROCESSING
GB2533892B (en) Compositions and methods
HK1219298A1 (zh) 用於檢測細菌污染的方法和組合物
AP2015008682A0 (en) Processing materials
EP2961779A4 (en) POLYETHYLENE PROCESSES AND COMPOSITIONS THEREOF
GB201308072D0 (en) Compositions and methods
HK1214305A1 (zh) 用於微生物捕集的方法和材料
HK1249918A1 (zh) 用於檢測過敏原的組合物和方法
EP2951580A4 (en) ARTICLES AND METHODS FOR RAPID DETECTION OF THC
GB201305813D0 (en) Compositions and methods
GB201308576D0 (en) Separation and analysis
ZA201607571B (en) Compositions and methods for detecting huanglongbing
GB201322456D0 (en) Radiotracer compositions and methods
EP2964610A4 (en) VINYL SULFON-BASED 18F LABELING COMPOSITIONS AND METHOD AND USES THEREOF
GB201322617D0 (en) Methods and compositions
GB201312393D0 (en) Compositions and Methods